Ayass BioScience Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Ayass BioScience's estimated annual revenue is currently $9.5M per year.(i)
  • Ayass BioScience's estimated revenue per employee is $216,000

Employee Data

  • Ayass BioScience has 44 Employees.(i)
  • Ayass BioScience grew their employee count by 63% last year.

Ayass BioScience's People

NameTitleEmail/Phone
1
Director, Flow Cytometry Core/Multiplex ImmunoassaysReveal Email/Phone
2
PresidentReveal Email/Phone
3
BioinformaticianReveal Email/Phone
4
BioinformaticianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.8M65-21%N/AN/A
#2
$7.8M360%N/AN/A
#3
$2.9M18-49%N/AN/A
#4
$48.7M1645%N/AN/A
#5
$27M1002%N/AN/A
#6
$73.4M2471%N/AN/A
#7
$13.9M59-8%$9.7MN/A
#8
$63.3M2135%N/AN/A
#9
$7.6M35-3%N/AN/A
#10
$1.8M11-8%N/AN/A
Add Company

What Is Ayass BioScience?

Ayass BioScience, LLC was established in 2014 with a mission to provide early disease detection, develop a disease monitoring system, and ultimately achieve better patient outcome by implementing Molecular Modern Medicine to daily clinical practice. We emphasize on Pathophysiology, Genetic, Epigenetic, and Proteomic/Metabolic profiling by conducting comprehensive immunologic testing, and next generation sequencing. Data collection and, more importantly, data interpretation through our bioinformatics and biostatistics department provides meaningful molecular analysis that guides precision medical practices. Our research in the field of Aptamers has opened the door to ground-breaking technology in the fields of both diagnostics and therapeutics. Our goal is to help clinicians implement unique precision medicine in their daily practice. Ayass BioScience, LLC (DBA as Ayass Lung Clinic, PLLC) is a CLIA certified laboratory performing advanced Next Generation Sequencing (Genetic Testing), Cardiac Conditions Hereditary Risk Assessment, Hereditary Cancer Risk Assessment, Neurological Conditions Genetic Predisposition Testing, also COVID-19 Testing (COVID-19 SARS-CoV-2 by RT-PCR), Pharmacogenetic Testing, Allergen Component-Resolved Testing, and Innovative Laboratory Testing. Ayass BioiScience, LLC is working on Aptamers Research and Testing. Ayass BioScience, LLC aims to be at the forefront of latest advancements in precision medicine to provide you with the most effective prevention and treatment options possible.

keywords:N/A

N/A

Total Funding

44

Number of Employees

$9.5M

Revenue (est)

63%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.5M44-8%N/A
#2
$6.2M440%N/A
#3
$5.1M44-20%N/A
#4
$11.6M4410%N/A
#5
$10.2M447%N/A